Botulinum toxin in the management of acquired motor fusion deficiency

Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which...

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Ramesh, Kesarwani, Siddharth
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812768/
https://www.ncbi.nlm.nih.gov/pubmed/19861751
http://dx.doi.org/10.4103/0301-4738.57162
_version_ 1782176858526187520
author Murthy, Ramesh
Kesarwani, Siddharth
author_facet Murthy, Ramesh
Kesarwani, Siddharth
author_sort Murthy, Ramesh
collection PubMed
description Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which was managed successfully with botulinum toxin injection.
format Text
id pubmed-2812768
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28127682010-02-08 Botulinum toxin in the management of acquired motor fusion deficiency Murthy, Ramesh Kesarwani, Siddharth Indian J Ophthalmol Brief Communications Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which was managed successfully with botulinum toxin injection. Medknow Publications 2009 /pmc/articles/PMC2812768/ /pubmed/19861751 http://dx.doi.org/10.4103/0301-4738.57162 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Murthy, Ramesh
Kesarwani, Siddharth
Botulinum toxin in the management of acquired motor fusion deficiency
title Botulinum toxin in the management of acquired motor fusion deficiency
title_full Botulinum toxin in the management of acquired motor fusion deficiency
title_fullStr Botulinum toxin in the management of acquired motor fusion deficiency
title_full_unstemmed Botulinum toxin in the management of acquired motor fusion deficiency
title_short Botulinum toxin in the management of acquired motor fusion deficiency
title_sort botulinum toxin in the management of acquired motor fusion deficiency
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812768/
https://www.ncbi.nlm.nih.gov/pubmed/19861751
http://dx.doi.org/10.4103/0301-4738.57162
work_keys_str_mv AT murthyramesh botulinumtoxininthemanagementofacquiredmotorfusiondeficiency
AT kesarwanisiddharth botulinumtoxininthemanagementofacquiredmotorfusiondeficiency

Ejemplares similares